Xianyu Luo
Wuxi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
GNF-5837 attenuates acute liver injury by inhibiting oxidative stress.
Journal: Molecular biology reports
Published: February 10, 2025
Covalent inhibition of ACSL4 alleviates ferroptosis-induced acute liver injury.
Journal: Cell chemical biology
Published: January 03, 2025
Merestinib inhibits cuproptosis by targeting NRF2 to alleviate acute liver injury.
Journal: Free radical biology & medicine
Published: September 21, 2024
Remodeling tumor immunosuppressive microenvironment through dual activation of immunogenic panoptosis and ferroptosis by H2S-amplified nanoformulation to enhance cancer immunotherapy.
Journal: Acta pharmaceutica Sinica. B
Published: August 28, 2024
Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases.
Journal: Science advances
Published: March 29, 2024
Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating iron.
Journal: International immunopharmacology
Published: February 14, 2024
Copper(II)-Based Nano-Regulator Correlates Cuproptosis Burst and Sequential Immunogenic Cell Death for Synergistic Cancer Immunotherapy.
Journal: Biomaterials research
Published: January 12, 2024
Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7.
Journal: Cell reports. Medicine
Published: April 17, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026